SomaLogic (SLGC)

SomaLogic (SLGC) Stock Price & Analysis


SLGC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.02 - $8.50
Previous Close$2.36
Average Volume (3M)989.38K
Market Cap
Enterprise Value-$123.78M
Total Cash (Recent Filing)$566.34M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.2
May 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding187,525,985
10 Day Avg. Volume1,036,616
30 Day Avg. Volume989,378
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)0.76
Price to Sales (P/S)5.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.22
Enterprise Value/Gross Profit-2.57
Enterprise Value/Ebitda1.54
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was SomaLogic’s price range in the past 12 months?
SomaLogic lowest stock price was $2.02 and its highest was $8.50 in the past 12 months.
    What is SomaLogic’s market cap?
    Currently, no data Available
    When is SomaLogic’s upcoming earnings report date?
    SomaLogic’s upcoming earnings report date is May 11, 2023 which is in 43 days.
      How were SomaLogic’s earnings last quarter?
      SomaLogic released its earnings results on Mar 28, 2023. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.218 by -$0.042.
        Is SomaLogic overvalued?
        According to Wall Street analysts SomaLogic’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does SomaLogic pay dividends?
          SomaLogic does not currently pay dividends.
          What is SomaLogic’s EPS estimate?
          SomaLogic’s EPS estimate is -$0.16.
            How many shares outstanding does SomaLogic have?
            SomaLogic has 187,525,990 shares outstanding.
              What happened to SomaLogic’s price movement after its last earnings report?
              SomaLogic reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.218. Following the earnings report the stock price went down -4.255%.
                Which hedge fund is a major shareholder of SomaLogic?
                Among the largest hedge funds holding SomaLogic’s share is ARK Investment Management LLC. It holds SomaLogic’s shares valued at 23M.


                  SomaLogic Stock Smart Score

                  The SomaLogic stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  CM Life Sciences II Inc is a blank check company.


                  Top 5 ETFs holding SLGC

                  Market Value
                  Smart Score
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Dimensional US Core Equity Market ETF
                  Direxion Fallen Knives ETF
                  BMO MSCI Innovation Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold SLGC. The ETFs are listed according to market value of SLGC within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adaptive Biotechnologies
                  BioNano Genomics
                  BioLife Solutions

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis